Immunotherapy for visceral leishmaniasis: ability of factors produced during anti-leishmania responses of skin test positive adults to inhibit peripheral blood mononuclear cell activities associated with visceral leishmaniasis.

Source:http://linkedlifedata.com/resource/pubmed/id/10029912

Download in:

View as

General Info

PMID
10029912